Loading…

The utility of serum osteopontin levels for predicting postoperative complications after colorectal cancer surgery

Background/Aim Osteopontin (OPN) is a secretory glycoprotein, which is expressed not only in osteoblasts, but immune cells including macrophages and activated T cells. Its pleiotropic immune functions, such as bone remodeling, cancer progression, immune response, and inflammation have been reported...

Full description

Saved in:
Bibliographic Details
Published in:International journal of clinical oncology 2022-11, Vol.27 (11), p.1706-1716
Main Authors: Sekiguchi, Kumiko, Matsuda, Akihisa, Yamada, Marina, Matsumoto, Satoshi, Sakurazawa, Nobuyuki, Kawano, Youichi, Yamada, Takeshi, Miyashita, Masao, Yoshida, Hiroshi
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c376t-3eb786f84619bde0f154b9ade42051489c8283f9b36c69b0b2bdb15df329b4c43
cites cdi_FETCH-LOGICAL-c376t-3eb786f84619bde0f154b9ade42051489c8283f9b36c69b0b2bdb15df329b4c43
container_end_page 1716
container_issue 11
container_start_page 1706
container_title International journal of clinical oncology
container_volume 27
creator Sekiguchi, Kumiko
Matsuda, Akihisa
Yamada, Marina
Matsumoto, Satoshi
Sakurazawa, Nobuyuki
Kawano, Youichi
Yamada, Takeshi
Miyashita, Masao
Yoshida, Hiroshi
description Background/Aim Osteopontin (OPN) is a secretory glycoprotein, which is expressed not only in osteoblasts, but immune cells including macrophages and activated T cells. Its pleiotropic immune functions, such as bone remodeling, cancer progression, immune response, and inflammation have been reported previously. However, the association between OPN and postoperative complications (POC) after colorectal cancer (CRC) surgery has not been studied, so far. Methods Peripheral blood samples were collected before (pre) and immediately after surgery (post), and on postoperative days (POD) 1, 3, 5, and 7. Serum OPN levels were measured by ELISA. In total, 78 patients who underwent elective CRC surgery were divided into the No-POC ( n  = 54) and POC ( n  = 24) groups. Results The POC group had significantly higher OPN levels than the No-POC group throughout the postoperative observation period. The maximum OPN levels from pre- to postsurgical samples showed the best predictive potential for POCs (cut off: 20.75 ng/mL, area under the curve: 0.724) and were correlated with length of postoperative stays. OPN values were significantly correlated with C-reactive protein on POD3 and were identified as an independent predictive marker for POCs (odds ratio: 3.88, 95% CI: 1.175–12.798, P  = 0.026). The severity of POCs was reflected in increased OPN levels. Conclusion Increased postoperative OPN was associated with increased postoperative inflammatory host responses and POC after CRC surgery. Serum OPN level may be a useful biomarker for early prediction of POC and it may provide additional information for treatment decisions to prevent POC.
doi_str_mv 10.1007/s10147-022-02225-6
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2701139434</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2701139434</sourcerecordid><originalsourceid>FETCH-LOGICAL-c376t-3eb786f84619bde0f154b9ade42051489c8283f9b36c69b0b2bdb15df329b4c43</originalsourceid><addsrcrecordid>eNp9kUtLxDAUhYso-PwDrgJu3FTzatIsRXzBgBtdhya9GTtkmpqkA_PvzTiC4MJFSO7hO4cbTlVdEnxDMJa3iWDCZY0p3R3a1OKgOiGcyVpKSQ_Lm3FSK0Gb4-o0pRXGRIqGnlTx7QPQnAc_5C0KDiWI8xqFlCFMYczDiDxswCfkQkRThH6wRVyiqSBhgtjlYQPIhvXkB1uGMCbUuQyxaD5EsLnzyHajLUqa4xLi9rw6cp1PcPFzn1Xvjw9v98_14vXp5f5uUVsmRa4ZGNkK13JBlOkBO9Jwo7oeOMUN4a2yLW2ZU4YJK5TBhprekKZ3jCrDLWdn1fU-d4rhc4aU9XpIFrzvRghz0lRiQpjibIde_UFXYY5j2U7TVmGOqeCkUHRP2RhSiuD0FId1F7eaYL2rQe9r0KUC_V2DFsXE9qZU4LH8_zf6H9cXGRCNBw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2890402641</pqid></control><display><type>article</type><title>The utility of serum osteopontin levels for predicting postoperative complications after colorectal cancer surgery</title><source>Springer Link</source><creator>Sekiguchi, Kumiko ; Matsuda, Akihisa ; Yamada, Marina ; Matsumoto, Satoshi ; Sakurazawa, Nobuyuki ; Kawano, Youichi ; Yamada, Takeshi ; Miyashita, Masao ; Yoshida, Hiroshi</creator><creatorcontrib>Sekiguchi, Kumiko ; Matsuda, Akihisa ; Yamada, Marina ; Matsumoto, Satoshi ; Sakurazawa, Nobuyuki ; Kawano, Youichi ; Yamada, Takeshi ; Miyashita, Masao ; Yoshida, Hiroshi</creatorcontrib><description>Background/Aim Osteopontin (OPN) is a secretory glycoprotein, which is expressed not only in osteoblasts, but immune cells including macrophages and activated T cells. Its pleiotropic immune functions, such as bone remodeling, cancer progression, immune response, and inflammation have been reported previously. However, the association between OPN and postoperative complications (POC) after colorectal cancer (CRC) surgery has not been studied, so far. Methods Peripheral blood samples were collected before (pre) and immediately after surgery (post), and on postoperative days (POD) 1, 3, 5, and 7. Serum OPN levels were measured by ELISA. In total, 78 patients who underwent elective CRC surgery were divided into the No-POC ( n  = 54) and POC ( n  = 24) groups. Results The POC group had significantly higher OPN levels than the No-POC group throughout the postoperative observation period. The maximum OPN levels from pre- to postsurgical samples showed the best predictive potential for POCs (cut off: 20.75 ng/mL, area under the curve: 0.724) and were correlated with length of postoperative stays. OPN values were significantly correlated with C-reactive protein on POD3 and were identified as an independent predictive marker for POCs (odds ratio: 3.88, 95% CI: 1.175–12.798, P  = 0.026). The severity of POCs was reflected in increased OPN levels. Conclusion Increased postoperative OPN was associated with increased postoperative inflammatory host responses and POC after CRC surgery. Serum OPN level may be a useful biomarker for early prediction of POC and it may provide additional information for treatment decisions to prevent POC.</description><identifier>ISSN: 1341-9625</identifier><identifier>EISSN: 1437-7772</identifier><identifier>DOI: 10.1007/s10147-022-02225-6</identifier><language>eng</language><publisher>Singapore: Springer Nature Singapore</publisher><subject>Bone cancer ; Bone remodeling ; C-reactive protein ; Cancer Research ; Colorectal cancer ; Colorectal carcinoma ; Complications ; Inflammation ; Lymphocytes T ; Macrophages ; Medicine ; Medicine &amp; Public Health ; Oncology ; Original Article ; Osteopontin ; Peripheral blood ; Postoperative ; Surgery ; Surgical Oncology</subject><ispartof>International journal of clinical oncology, 2022-11, Vol.27 (11), p.1706-1716</ispartof><rights>The Author(s) under exclusive licence to Japan Society of Clinical Oncology 2022. Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c376t-3eb786f84619bde0f154b9ade42051489c8283f9b36c69b0b2bdb15df329b4c43</citedby><cites>FETCH-LOGICAL-c376t-3eb786f84619bde0f154b9ade42051489c8283f9b36c69b0b2bdb15df329b4c43</cites><orcidid>0000-0002-6468-9375</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids></links><search><creatorcontrib>Sekiguchi, Kumiko</creatorcontrib><creatorcontrib>Matsuda, Akihisa</creatorcontrib><creatorcontrib>Yamada, Marina</creatorcontrib><creatorcontrib>Matsumoto, Satoshi</creatorcontrib><creatorcontrib>Sakurazawa, Nobuyuki</creatorcontrib><creatorcontrib>Kawano, Youichi</creatorcontrib><creatorcontrib>Yamada, Takeshi</creatorcontrib><creatorcontrib>Miyashita, Masao</creatorcontrib><creatorcontrib>Yoshida, Hiroshi</creatorcontrib><title>The utility of serum osteopontin levels for predicting postoperative complications after colorectal cancer surgery</title><title>International journal of clinical oncology</title><addtitle>Int J Clin Oncol</addtitle><description>Background/Aim Osteopontin (OPN) is a secretory glycoprotein, which is expressed not only in osteoblasts, but immune cells including macrophages and activated T cells. Its pleiotropic immune functions, such as bone remodeling, cancer progression, immune response, and inflammation have been reported previously. However, the association between OPN and postoperative complications (POC) after colorectal cancer (CRC) surgery has not been studied, so far. Methods Peripheral blood samples were collected before (pre) and immediately after surgery (post), and on postoperative days (POD) 1, 3, 5, and 7. Serum OPN levels were measured by ELISA. In total, 78 patients who underwent elective CRC surgery were divided into the No-POC ( n  = 54) and POC ( n  = 24) groups. Results The POC group had significantly higher OPN levels than the No-POC group throughout the postoperative observation period. The maximum OPN levels from pre- to postsurgical samples showed the best predictive potential for POCs (cut off: 20.75 ng/mL, area under the curve: 0.724) and were correlated with length of postoperative stays. OPN values were significantly correlated with C-reactive protein on POD3 and were identified as an independent predictive marker for POCs (odds ratio: 3.88, 95% CI: 1.175–12.798, P  = 0.026). The severity of POCs was reflected in increased OPN levels. Conclusion Increased postoperative OPN was associated with increased postoperative inflammatory host responses and POC after CRC surgery. Serum OPN level may be a useful biomarker for early prediction of POC and it may provide additional information for treatment decisions to prevent POC.</description><subject>Bone cancer</subject><subject>Bone remodeling</subject><subject>C-reactive protein</subject><subject>Cancer Research</subject><subject>Colorectal cancer</subject><subject>Colorectal carcinoma</subject><subject>Complications</subject><subject>Inflammation</subject><subject>Lymphocytes T</subject><subject>Macrophages</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Oncology</subject><subject>Original Article</subject><subject>Osteopontin</subject><subject>Peripheral blood</subject><subject>Postoperative</subject><subject>Surgery</subject><subject>Surgical Oncology</subject><issn>1341-9625</issn><issn>1437-7772</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNp9kUtLxDAUhYso-PwDrgJu3FTzatIsRXzBgBtdhya9GTtkmpqkA_PvzTiC4MJFSO7hO4cbTlVdEnxDMJa3iWDCZY0p3R3a1OKgOiGcyVpKSQ_Lm3FSK0Gb4-o0pRXGRIqGnlTx7QPQnAc_5C0KDiWI8xqFlCFMYczDiDxswCfkQkRThH6wRVyiqSBhgtjlYQPIhvXkB1uGMCbUuQyxaD5EsLnzyHajLUqa4xLi9rw6cp1PcPFzn1Xvjw9v98_14vXp5f5uUVsmRa4ZGNkK13JBlOkBO9Jwo7oeOMUN4a2yLW2ZU4YJK5TBhprekKZ3jCrDLWdn1fU-d4rhc4aU9XpIFrzvRghz0lRiQpjibIde_UFXYY5j2U7TVmGOqeCkUHRP2RhSiuD0FId1F7eaYL2rQe9r0KUC_V2DFsXE9qZU4LH8_zf6H9cXGRCNBw</recordid><startdate>20221101</startdate><enddate>20221101</enddate><creator>Sekiguchi, Kumiko</creator><creator>Matsuda, Akihisa</creator><creator>Yamada, Marina</creator><creator>Matsumoto, Satoshi</creator><creator>Sakurazawa, Nobuyuki</creator><creator>Kawano, Youichi</creator><creator>Yamada, Takeshi</creator><creator>Miyashita, Masao</creator><creator>Yoshida, Hiroshi</creator><general>Springer Nature Singapore</general><general>Springer Nature B.V</general><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7TO</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>H94</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>MBDVC</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-6468-9375</orcidid></search><sort><creationdate>20221101</creationdate><title>The utility of serum osteopontin levels for predicting postoperative complications after colorectal cancer surgery</title><author>Sekiguchi, Kumiko ; Matsuda, Akihisa ; Yamada, Marina ; Matsumoto, Satoshi ; Sakurazawa, Nobuyuki ; Kawano, Youichi ; Yamada, Takeshi ; Miyashita, Masao ; Yoshida, Hiroshi</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c376t-3eb786f84619bde0f154b9ade42051489c8283f9b36c69b0b2bdb15df329b4c43</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Bone cancer</topic><topic>Bone remodeling</topic><topic>C-reactive protein</topic><topic>Cancer Research</topic><topic>Colorectal cancer</topic><topic>Colorectal carcinoma</topic><topic>Complications</topic><topic>Inflammation</topic><topic>Lymphocytes T</topic><topic>Macrophages</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Oncology</topic><topic>Original Article</topic><topic>Osteopontin</topic><topic>Peripheral blood</topic><topic>Postoperative</topic><topic>Surgery</topic><topic>Surgical Oncology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sekiguchi, Kumiko</creatorcontrib><creatorcontrib>Matsuda, Akihisa</creatorcontrib><creatorcontrib>Yamada, Marina</creatorcontrib><creatorcontrib>Matsumoto, Satoshi</creatorcontrib><creatorcontrib>Sakurazawa, Nobuyuki</creatorcontrib><creatorcontrib>Kawano, Youichi</creatorcontrib><creatorcontrib>Yamada, Takeshi</creatorcontrib><creatorcontrib>Miyashita, Masao</creatorcontrib><creatorcontrib>Yoshida, Hiroshi</creatorcontrib><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>ProQuest - Health &amp; Medical Complete保健、医学与药学数据库</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database (Proquest)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>ProQuest research library</collection><collection>Research Library (Corporate)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>International journal of clinical oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sekiguchi, Kumiko</au><au>Matsuda, Akihisa</au><au>Yamada, Marina</au><au>Matsumoto, Satoshi</au><au>Sakurazawa, Nobuyuki</au><au>Kawano, Youichi</au><au>Yamada, Takeshi</au><au>Miyashita, Masao</au><au>Yoshida, Hiroshi</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The utility of serum osteopontin levels for predicting postoperative complications after colorectal cancer surgery</atitle><jtitle>International journal of clinical oncology</jtitle><stitle>Int J Clin Oncol</stitle><date>2022-11-01</date><risdate>2022</risdate><volume>27</volume><issue>11</issue><spage>1706</spage><epage>1716</epage><pages>1706-1716</pages><issn>1341-9625</issn><eissn>1437-7772</eissn><abstract>Background/Aim Osteopontin (OPN) is a secretory glycoprotein, which is expressed not only in osteoblasts, but immune cells including macrophages and activated T cells. Its pleiotropic immune functions, such as bone remodeling, cancer progression, immune response, and inflammation have been reported previously. However, the association between OPN and postoperative complications (POC) after colorectal cancer (CRC) surgery has not been studied, so far. Methods Peripheral blood samples were collected before (pre) and immediately after surgery (post), and on postoperative days (POD) 1, 3, 5, and 7. Serum OPN levels were measured by ELISA. In total, 78 patients who underwent elective CRC surgery were divided into the No-POC ( n  = 54) and POC ( n  = 24) groups. Results The POC group had significantly higher OPN levels than the No-POC group throughout the postoperative observation period. The maximum OPN levels from pre- to postsurgical samples showed the best predictive potential for POCs (cut off: 20.75 ng/mL, area under the curve: 0.724) and were correlated with length of postoperative stays. OPN values were significantly correlated with C-reactive protein on POD3 and were identified as an independent predictive marker for POCs (odds ratio: 3.88, 95% CI: 1.175–12.798, P  = 0.026). The severity of POCs was reflected in increased OPN levels. Conclusion Increased postoperative OPN was associated with increased postoperative inflammatory host responses and POC after CRC surgery. Serum OPN level may be a useful biomarker for early prediction of POC and it may provide additional information for treatment decisions to prevent POC.</abstract><cop>Singapore</cop><pub>Springer Nature Singapore</pub><doi>10.1007/s10147-022-02225-6</doi><tpages>11</tpages><orcidid>https://orcid.org/0000-0002-6468-9375</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 1341-9625
ispartof International journal of clinical oncology, 2022-11, Vol.27 (11), p.1706-1716
issn 1341-9625
1437-7772
language eng
recordid cdi_proquest_miscellaneous_2701139434
source Springer Link
subjects Bone cancer
Bone remodeling
C-reactive protein
Cancer Research
Colorectal cancer
Colorectal carcinoma
Complications
Inflammation
Lymphocytes T
Macrophages
Medicine
Medicine & Public Health
Oncology
Original Article
Osteopontin
Peripheral blood
Postoperative
Surgery
Surgical Oncology
title The utility of serum osteopontin levels for predicting postoperative complications after colorectal cancer surgery
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T06%3A15%3A56IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20utility%20of%20serum%20osteopontin%20levels%20for%20predicting%20postoperative%20complications%20after%20colorectal%20cancer%20surgery&rft.jtitle=International%20journal%20of%20clinical%20oncology&rft.au=Sekiguchi,%20Kumiko&rft.date=2022-11-01&rft.volume=27&rft.issue=11&rft.spage=1706&rft.epage=1716&rft.pages=1706-1716&rft.issn=1341-9625&rft.eissn=1437-7772&rft_id=info:doi/10.1007/s10147-022-02225-6&rft_dat=%3Cproquest_cross%3E2701139434%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c376t-3eb786f84619bde0f154b9ade42051489c8283f9b36c69b0b2bdb15df329b4c43%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2890402641&rft_id=info:pmid/&rfr_iscdi=true